TY - JOUR
T1 - Corrigendum
T2 - RUNX2 Phosphorylation by Tyrosine Kinase ABL Promotes Breast Cancer Invasion (Front. Oncol., (2021), 11, 10.3389/fonc.2021.665273)
AU - He, Fang
AU - Matsumoto, Yoshinori
AU - Asano, Yosuke
AU - Yamamura, Yuriko
AU - Katsuyama, Takayuki
AU - Rose, Jose La
AU - Tomonobu, Nahoko
AU - Komalasari, Ni Luh Gede Yoni
AU - Sakaguchi, Masakiyo
AU - Rottapel, Robert
AU - Wada, Jun
N1 - Publisher Copyright:
© 2021 He, Matsumoto, Asano, Yamamura, Katsuyama, Rose, Tomonobu, Komalasari, Sakaguchi, Rottapel and Wada.
PY - 2021/7/20
Y1 - 2021/7/20
N2 - In the original article, there was a mistake in Figures 1A, B, D, F, 2D, 3B–D, F, 4D, S5A as published. We noticed that several qPCR data were not correctly normalized since the calculation program of the DCt method did not work. The corrected Figures 1A, B, D, F, 2D, 3B–D, F, 4D, S5A and the equivalent raw data in Figures S1–S4 and S5A appears below. The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
AB - In the original article, there was a mistake in Figures 1A, B, D, F, 2D, 3B–D, F, 4D, S5A as published. We noticed that several qPCR data were not correctly normalized since the calculation program of the DCt method did not work. The corrected Figures 1A, B, D, F, 2D, 3B–D, F, 4D, S5A and the equivalent raw data in Figures S1–S4 and S5A appears below. The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
KW - ABL—Abelson murine leukemia viral oncogene homolog
KW - Runx2 (runt-related transcription factor 2)
KW - invasion
KW - phosphorylation
KW - tyrosine
UR - http://www.scopus.com/inward/record.url?scp=85111932710&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85111932710&partnerID=8YFLogxK
U2 - 10.3389/fonc.2021.729192
DO - 10.3389/fonc.2021.729192
M3 - Comment/debate
AN - SCOPUS:85111932710
SN - 2234-943X
VL - 11
JO - Frontiers in Oncology
JF - Frontiers in Oncology
M1 - 729192
ER -